Real-World Plasma Thymidine Kinase Activity in High-Risk and Metastatic Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer Treated With Cyclin-Dependent Kinase ...
Researchers from the Faculty of Engineering at The University of Hong Kong (HKU) have developed two innovative deep-learning ...
The global HLA typing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% during the ...
Medical Device Network on MSN
Quest launches flow cytometry MRD test for myeloma
Quest expects the new blood test will support response monitoring in clinical trials.
Quest Diagnostics , a leading provider of diagnostic information services, today announced the launch of a novel blood test that uses advanced flow cytometry methods to assess measurable residual ...
Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...
Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...
We came across a bullish thesis on Twist Bioscience Corporation on Clinical Catalysts’s Substack. In this article, we will ...
Each wall system brings specific characteristics to a project...Evaluating factors like structural demands, energy ...
Transatlantic genomics company Quotient Therapeutics has handed Susan Keefe the CFO role on a permanent basis.
With Q3 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers. The life sciences tools and services sector ...
Expecting very active 2026 from a clinical perspective, including significant patient accrual completions and subsequent data readouts from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results